EG Labs Find Unidentified Ingredient in Male Enhancement Drug

By: Katie Kelley Click author's name for more of his/her articles

With the cultural acceptance of sexual enhancement products and drugs within the American society has come a billion-dollar a year profitable entity.

Often, these products promise remarkable outcomes for patients. However, many times, these products are nothing more than a potentially dangerous cocktail of "herbal" supplements or fillers.

EG Labs Announces Viapro Recall

On July 23rd, 2008, EG Labs, LLC, released a statement voluntarily recalling all lots of their drug Viapro, a sexual enhancement medication. This announcement comes after the company was informed by representatives of the Food and Drug Administration (FDA) that lab analysis of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, thio-methisosildenafil.

The FDA describes this ingredient is an analog of sildenafil. When a chemical compound is made up of one or more atoms that are replaced from a parent compound that has similar chemical makeup but with a differing interaction it is also known as an analog. The FDA has approved sildenafil, which is the active ingredient in erectile dysfunction.

Dangerous Interactions

The danger lies in the interaction with potentially harmful interactions with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. Prescription medications that commonly contain nitrates include drugs treating heart disease, diabetes, high blood pressure and high cholesterol. Men may be adversely affected by various sexually-induced side effects due to pre-existing conditions or medicinal side effects.

However, because the unidentified ingredient known as thiomethisosildenafil can be a fatal mix with nitrates, patients must be warned of the risk that a deadly drop in blood pressure could occur.

Up until March 2008, Viapro was being sold not only in pharmacies but in health food stores and other vitamin retails nation-wide. They were packaged into 2-capsule blister, 1 capsule blister and 10 capsule bottles. Although Viapro has been recalled, it is still being sold at some online retailers, which could increase the risk of negative responses among patients.

Full FDA Recall Underway

The FDA has requested that any adverse events that may be related to the use of this product be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088 or by fax at 1-800-FDA-0178 or by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787.

Any patient who believes they may have been negatively affected by Viapro, whether it was marketed as Viapro or some other brand, should immediately contact a health professional to evaluate their condition. Individuals who have suffered as a result of their consumption of Viapro should consult with not only a medical physician but also with a knowledgeable pharmaceutical lawyer to learn about developing a Viapro class action lawsuit.

Copyright (c) 2008 Katie Kelley

Article Source: ABC Article Directory

About The Author: Additional information on the Viapro recall is available at viapro.legalview.com or at www.LegalView.com/. Learn about other medical products and medications that are also endangering Americans including the Zimmer Durom cup risks. Readers can also find information on how to locate a pharmaceutical lawyer for developing a Levaquin lawsuit, which is the antibiotic linked to tendon rupture among patients.